Since its inception Manhattan Scientifics Inc. has been a technology developer that nurtures financially promising technologies with potential global commercial applications. The company and its affiliates now own a significant IP portfolio and patents in high-strength metals, early cancer detection, alternative energy, hydrogen fuel cells and computer 3D touch haptics.

The company’s business model is to commercialize, bringing products to market to create profit for its shareholders through partnerships with manufacturers and licensees of its patents.